Modeling Principle

The Pig Reproducible ARDS Model adopts a double-hit protocol of intratracheal nebulized lipopolysaccharide (LPS) combined with controlled high plateau pressure mechanical ventilation, to construct a highly stable and reproducible standardized large-animal acute respiratory distress syndrome pathological model recognized by SCI. It accurately recapitulates the core pathological process of clinical ARDS: LPS induces acute injury of alveolar epithelium and vascular endothelium, massive burst release of pro-inflammatory factors triggers pulmonary inflammatory cascade; superimposed high-pressure ventilation causes alveolar overdistension leading to ventilator-induced lung injury (VILI). The double hits destroy the integrity of the alveolar-capillary barrier, massive proteinaceous fluid and inflammatory cells leak into the alveolar space and pulmonary interstitium, resulting in diffuse alveolar damage (DAD), pulmonary interstitial & alveolar edema, hyaline membrane formation and pulmonary consolidation, followed by sharp decline of lung compliance, refractory hypoxemia, severe ventilation/perfusion mismatch and progressive respiratory failure. This model overcomes the drawbacks of rodents such as tiny respiratory system size, differences in pulmonary lobular structure, airway mechanics, alveolar barrier tolerance threshold, intensity of systemic inflammatory response and evolutionary law of respiratory mechanical parameters compared with human ARDS, poor experimental reproducibility and limited clinical translational value of data.

The pulmonary lobular anatomical structure, airway tree hierarchy, alveolar size and density, physiological function of type Ⅰ/Ⅱ alveolar epithelium, characteristics of pulmonary microvascular endothelial barrier, neutrophil infiltration pattern, NF-κB-mediated inflammatory pathway, pulmonary water-sodium transport mechanism and respiratory mechanical response curve of adult domestic pigs are highly homologous to human lungs. Experimental animals are intubated under general anesthesia to establish an invasive mechanical ventilation baseline access. Standard concentration of Escherichia coli LPS solution is delivered via airway nebulization; endotoxin activates pulmonary innate immune cells to release abundant pro-inflammatory mediators including TNF-α, IL-1β, IL-6 and HMGB1. Simultaneously, controlled mechanical ventilation is performed with plateau pressure higher than the physiological safety threshold, and repeated overstretching of alveoli causes mechanical stress injury. Dual injuries synergistically amplify local pulmonary and systemic inflammatory responses, vascular endothelial gaps open and alveolar epithelial permeability is impaired. Plasma proteins and inflammatory cells massively extravasate and deposit in pulmonary interstitium and alveolar lumens, accompanied by extensive hyaline membrane formation, pulmonary consolidation and elevated lung water content. Lung compliance and oxygenation index decrease persistently, forming a typical ARDS pathological phenotype with stable status and extremely low batch-to-batch variation. This model fully recapitulates the classic pathogenic cascade of clinical ARDS: primary pulmonary inflammatory injury induced by endotoxin + secondary biomechanical injury from mechanical ventilation → rupture of alveolar-capillary barrier → pulmonary edema, hyaline membrane and diffuse alveolar damage → refractory hypoxemia and deteriorated respiratory mechanics → acute respiratory distress syndrome.

Pigs have moderate body size and thick airways for accurate drug administration and ventilation control. LPS dosage, ventilation pressure and ventilation duration can be quantitatively standardized with high modeling success rate and ultra-low intra-group and batch dispersion, realizing excellent experimental reproducibility. Three pathological stages can be clearly distinguished: early inflammation initiation stage induced by LPS, progressive edema stage with amplified inflammation aggravated by superimposed ventilatory injury, and terminal stable formation stage of structural and functional damage typical of ARDS. It serves as a standardized large-animal gold-standard model for translational researches on ARDS targeted anti-inflammatory drugs, lung protective ventilation strategies, alveolar barrier protective agents, ECMO supporting protocols and pulmonary targeted delivery systems.

Modeling Success Criteria

In-vivo Respiratory Mechanics, Blood Gas and General Lung Morphological Phenotype

PaO₂/FiO₂ of the sham group remained above 300 mmHg throughout the experiment with normal lung compliance. Isolated lungs were soft and uniformly pink without congestion and edema. PaO₂ of the model group was continuously ≤150 mmHg at the 24 h endpoint (meeting the diagnostic threshold for moderate-severe ARDS), and static lung compliance decreased significantly compared with baseline. Gross lungs were swollen with dark red congestion, and a large amount of foamy edema fluid overflowed from the cut surface. The lung wet/dry ratio increased remarkably compared with the control group, presenting typical macroscopic ARDS phenotype with extremely significant statistical difference between groups, confirming the model can be stably reproduced with successful modeling.

Quantitative Biochemical Gold-Standard Indexes in Serum and BALF

The concentrations of TNF-α, IL-1β, IL-6 and HMGB1 in serum and BALF of the model group were significantly increased in multiples compared with the sham group. The expressions of VE-cadherin and AQP1/AQP5 in lung tissues were down-regulated, indicating damage of vascular endothelial and alveolar epithelial barriers. The lung wet/dry ratio increased obviously, which fully conforms to the biochemical characteristics of clinical ARDS: inflammatory factor storm, endothelial-alveolar barrier leakage and permeable pulmonary edema.

Lung Histopathological Characteristics

Sequential pathological injuries are observed via combined staining of lung tissues with HE, PAS, Masson and TUNEL:

1. 6 h after modeling: a small amount of inflammatory cell infiltration in alveolar septa, early apoptotic changes of alveolar epithelium and slight protein exudation in alveolar cavity;
2. 16 h after modeling: massive neutrophil infiltration in pulmonary interstitium, thickened alveolar wall, accumulation of edema fluid in alveolar cavity and initial formation of thin hyaline membrane locally;
3. Terminal stage at 24 h after modeling: extensive diffuse alveolar damage (DAD), disordered and collapsed alveolar structure, massive hyaline membrane formation in alveolar cavity, thickened pulmonary interstitial edema accompanied by abundant inflammatory infiltration, and markedly increased number of apoptotic alveolar epithelial cells, which perfectly reproduces the characteristic pathological changes of clinical ARDS.

Gold-Standard Indexes for Inflammatory and Alveolar Barrier Pathways

LPS activates the NF-κB signaling pathway of pulmonary macrophages to release abundant pro-inflammatory factors and induce systemic inflammatory response. Superimposed high-pressure ventilation causes mechanical stretch injury of alveoli and further amplifies inflammatory signals, down-regulates the expression of VE-cadherin and aquaporins, leads to abnormally elevated alveolar-capillary permeability, massive leakage of plasma components to form permeable pulmonary edema, and finally results in DAD, hyaline membrane and refractory hypoxemia. It accurately conforms to the complete pathological mechanism of reproducible ARDS constructed by dual insult: primary inflammatory injury induced by endotoxin + secondary biomechanical injury from mechanical ventilation → elevated barrier permeability → formation of pulmonary edema and DAD → respiratory function injury of ARDS, serving as the core academic basis for judging the reliability and reproducibility of the model.

Model Advantages

This model is a well-recognized pig reproducible ARDS gold-standard model constructed by LPS combined with controllable high-pressure ventilation in critical care and respiratory pharmacology SCI fields. The 24-hour standardized closed-loop operation process brings extremely small inter-batch and intra-group differences with outstanding reproducibility. The pulmonary anatomy, ventilation mechanics, inflammatory response and alveolar injury pattern of pigs are highly homologous to humans, and the dual-insult mode conforms to the real clinical pathogenesis of ARDS jointly induced by sepsis and mechanical ventilation. All modeling parameters are quantified and fixed, and artificial operational variables are controlled to the maximum extent with high data stability. Real-time continuous monitoring of dynamic changes in respiration and hemodynamics can be realized, and multi-time-point sampling is available to construct dynamic evolution curves. It is suitable for preclinical efficacy and safety evaluation of new ARDS targeted drugs, lung protective ventilation strategies, ECMO parameter optimization, atomized preparations and vascular endothelial protection schemes. Experimental data are widely accepted by high-impact SCI journals of critical care medicine, respiratory medicine and pharmaceutics, applicable for National Natural Science Foundation projects, master & doctoral graduation theses and translational medical researches on ARDS treatment.

Research Applications

The Pig Reproducible ARDS Model is mainly used to analyze the pathological mechanisms including activation of pulmonary NF-κB inflammatory pathway stimulated by intratracheal LPS, massive release of pro-inflammatory factors damaging alveolar epithelial-endothelial barrier, amplified inflammatory response induced by mechanical stretch from high-pressure ventilation, elevated alveolar permeability triggering pulmonary edema, as well as hypoxic respiratory distress caused by diffuse alveolar damage and hyaline membrane formation. It is adopted to screen and verify intravenous/nebulized new anti-ARDS drugs, optimized ventilation strategies, extracorporeal life support parameters, pulmonary targeted nano delivery systems and natural anti-inflammatory active components with functions of inhibiting pulmonary inflammatory cascade, protecting the integrity of alveolar-capillary barrier, alleviating permeable pulmonary edema, improving lung compliance and oxygenation, and relieving DAD pathological injury. It is widely used for excavation of pathogenic molecular targets of ARDS lung injury, elucidation of interactive regulatory network between inflammation and barrier injury, and preclinical in-vivo efficacy verification of various medical products for ARDS treatment in large animals. It is an essential standardized reproducible large-animal gold-standard model for researches in the fields of critical care pharmacology, acute lung injury and mechanical ventilation.

pig reproducible acute respiratory distress syndrome model, lipopolysaccharide combined with mechanical ventilation, alveolar-capillary barrier damage, diffuse alveolar damage (DAD), pulmonary inflammatory cascade, anti-ARDS drugs & lung protective ventilation strategy preclinical evaluation